InflaRx IFRX
NASDAQ IFRX
$2.10 +0.08 (+3.96%)
At close: Aug 21, 2026 · 4:00 PM EDT

InflaRx (IFRX) Other Operating Expenses (2016 - 2026)

InflaRx (IFRX) posted Other Operating Expenses of -$126524.8 for Q1 2026, up 90.75% sequentially from -$1.4 million in Q3 2025, and up 91.75% YoY from -$65984.3 in Q1 2025.

InflaRx (IFRX) Other Operating Expenses (2016 - 2026) Analysis & Trends

InflaRx has reported Other Operating Expenses for 11 years, with the latest figure at -$126524.8 in Q1 2026.

  • Quarterly Other Operating Expenses rose 91.75% year-over-year to -$126524.8 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.5 million (up 56.18% YoY) and the FY2022 annual result came in at -$55223.0 billion, down 21808543.69% from the prior year.
  • Other Operating Expenses improved to -$126524.8 in Q1 2026 per IFRX's latest filing, from -$1.4 million in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $19685.6 billion in Q1 2023 and troughed at -$53456.5 billion in Q4 2022.
  • A 5-year average of -$4448.3 billion and a median of -$1.6 million in 2023 frame the typical range for Other Operating Expenses.
  • The sharpest annual moves came in 2022 and 2023: Other Operating Expenses tumbled 5.7512495248749355e+23% in 2022, then soared 100.0% in 2023.
  • Over 5 years, Other Operating Expenses stood at -$53456.5 billion in 2022, then surged by 100.0% to -$1.7 million in 2023, then fell by 10.26% to -$1.9 million in 2024, then climbed by 27.1% to -$1.4 million in 2025, then soared by 90.75% to -$126524.8 in 2026.
  • According to Business Quant data, Other Operating Expenses over the past three periods registered -$126524.8, -$1.4 million, and -$1.5 million for Q1 2026, Q3 2025, and Q1 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 InflaRx 140.30 Mn -43.96 Mn 2.74 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 -126,524.82
Sep 30, 2025 -1.37 Mn
Mar 31, 2025 -1.53 Mn
Sep 30, 2024 -1.88 Mn
Mar 31, 2024 -1.59 Mn
Sep 30, 2023 -1.70 Mn
Mar 31, 2023 19,685.57 Bn
Dec 31, 2022 -53,456.47 Bn
Sep 30, 2022 -10,712.54 Bn
Jun 30, 2022 -23.86 Mn
Sep 30, 2021 0.00
Jun 30, 2021 -27.21 Mn
Mar 31, 2021 -1.21
Mar 31, 2020 1.10
Dec 31, 2019 0.01
Jun 30, 2019 0.00
Dec 31, 2018 1.14 Mn
Sep 30, 2018 68,624.62
Jun 30, 2018 52,511.55
Mar 31, 2018 85,997.30